Gufic BioSciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 509079 |
NSE Symbol : GUFICBIO |
P/E(TTM) : 46.49 |
ISIN Demat : INE742B01025 |
Div & Yield% : 0.02 |
EPS(TTM) : 8.61 |
Book Value(₹) : 53.11 |
Market Cap(₹Cr) : 4,013.61 |
Face Value(₹) : 1.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 202.81 | 194.99 | 201.78 | 214.87 | 195.02 | 173.04 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 202.81 | 194.99 | 201.78 | 214.87 | 195.02 | 173.04 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 1.25 | 0.88 | 0.42 | 0.33 | 0.88 | 0.62 |
Total Income | 204.07 | 195.87 | 202.20 | 215.21 | 195.90 | 173.66 |
Total Expenditure | 167.03 | 160.77 | 165.32 | 175.50 | 159.54 | 140.89 |
PBIDT | 37.04 | 35.11 | 36.88 | 39.70 | 36.36 | 32.77 |
Interest | 4.62 | 3.65 | 3.18 | 4.46 | 4.07 | 2.92 |
PBDT | 32.41 | 31.46 | 33.70 | 35.24 | 32.29 | 29.85 |
Depreciation | 4.31 | 4.34 | 4.14 | 4.30 | 4.24 | 5.92 |
Tax | 7.00 | 7.30 | 7.20 | 5.37 | 6.50 | 6.20 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.25 | -0.23 | 0.10 | 2.36 | 0.93 | -0.37 |
Reported Profit After Tax | 20.86 | 20.05 | 22.26 | 23.21 | 20.62 | 18.11 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 20.86 | 20.05 | 22.26 | 23.21 | 20.62 | 18.11 |
EPS (Unit Curr.) | 2.08 | 2.00 | 2.23 | 2.39 | 2.13 | 1.87 |
EPS (Adj) (Unit Curr.) | 2.08 | 2.00 | 2.23 | 2.39 | 2.13 | 1.87 |
Calculated EPS (Unit Curr.) | 2.08 | 2.00 | 2.22 | 2.39 | 2.13 | 1.87 |
Calculated EPS (Adj) (Unit Curr.) | 2.08 | 2.00 | 2.22 | 2.39 | 2.13 | 1.87 |
Calculated EPS (Ann.) (Unit Curr.) | 8.32 | 8.00 | 8.88 | 9.58 | 8.51 | 7.47 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 8.32 | 8.00 | 8.88 | 9.58 | 8.51 | 7.47 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 10.03 | 10.03 | 10.03 | 9.69 | 9.69 | 9.69 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 18.26 | 18.01 | 18.28 | 18.48 | 18.64 | 18.94 |
PBDTM(%) | 15.98 | 16.13 | 16.70 | 16.40 | 16.56 | 17.25 |
PATM(%) | 10.29 | 10.28 | 11.03 | 10.80 | 10.57 | 10.47 |